BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28539956)

  • 21. Metabolic Effects of Antidepressant Treatment.
    Olguner Eker Ö; Özsoy S; Eker B; Doğan H
    Noro Psikiyatr Ars; 2017 Mar; 54(1):49-56. PubMed ID: 28566959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the management of diabetic neuropathy.
    Várkonyi T; Körei A; Putz Z; Martos T; Keresztes K; Lengyel C; Nyiraty S; Stirban A; Jermendy G; Kempler P
    Minerva Med; 2017 Oct; 108(5):419-437. PubMed ID: 28541026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escitalopram or novel herbal treatments differentially alter cytokine and behavioral responses to immune challenge.
    Avitsur R; Paley S; Franko M; Wolff N; Eyal N; Doron R
    J Neuroimmunol; 2017 Aug; 309():111-118. PubMed ID: 28601279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing Highly Benefited Patients in Randomized Clinical Trials.
    Charu V; Rosenberg PB; Schneider LS; Drye LT; Rein L; Shade D; Lyketsos CG; Frangakis CE
    Int J Biostat; 2017 May; 13(1):. PubMed ID: 28541924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients.
    Jiang H; Chen S; Lu N; Yue Y; Yin Y; Zhang Y; Jiang W; Liang J; Yuan Y
    World J Biol Psychiatry; 2017 Dec; 18(8):586-591. PubMed ID: 28635540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
    Sindrup SH; Holbech J; Demant D; Finnerup NB; Bach FW; Jensen TS
    Eur J Pain; 2017 Sep; 21(8):1443-1450. PubMed ID: 28557178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between cytochrome P450 2C19 genetic polymorphism and treatment response to escitalopram in panic disorder.
    He Q; Yuan Z; Liu Y; Zhang J; Yan H; Shen L; Luo X; Zhang Y
    Pharmacogenet Genomics; 2017 Aug; 27(8):279-284. PubMed ID: 28614176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated co-treatment with antidepressants and risperidone increases BDNF mRNA and protein levels in rats.
    Rogóż Z; Kamińska K; Pańczyszyn-Trzewik P; Sowa-Kućma M
    Pharmacol Rep; 2017 Oct; 69(5):885-893. PubMed ID: 28624596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serotonergic 5HTTLPR/rs25531 s-allele homozygosity associates with violent suicides in male citalopram users.
    Rahikainen AL; Majaharju S; Haukka J; Palo JU; Sajantila A
    Am J Med Genet B Neuropsychiatr Genet; 2017 Oct; 174(7):691-700. PubMed ID: 28608626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety.
    Gammoh O; Mayyas F; Darwish Elhajji F
    Biomed Rep; 2017 Jun; 6(6):675-680. PubMed ID: 28584640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stable Remission of Multiple Chemical Sensitivity Syndrome and Major Depression With Citalopram and 1-Month Deep Transcranial Magnetic Stimulation: A Case Report.
    Del Casale A; Rapinesi C; Kotzalidis GD; Sorice S; Padovano A; Gentile G; Angeletti G; Ferracuti S; Sani G; Pompili M; Simmaco M; Girardi P
    J ECT; 2017 Sep; 33(3):e27-e29. PubMed ID: 28570499
    [No Abstract]   [Full Text] [Related]  

  • 32. Statin and Its Association With Delirium in the Medical ICU.
    Mather JF; Corradi JP; Waszynski C; Noyes A; Duan Y; Grady J; Dicks R
    Crit Care Med; 2017 Sep; 45(9):1515-1522. PubMed ID: 28622167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregabalin and heart failure: A population-based study.
    Ho JM; Macdonald EM; Luo J; Gomes T; Antoniou T; Mamdani MM; Juurlink DN
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1087-1092. PubMed ID: 28620909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors.
    Roy S; Weinstock JL; Ishino AS; Benites JF; Pop SR; Perez CD; Gumbs EA; Rosenbaum JA; Roccato MK; Shah H; Contino G; Hunter K
    J Clin Med Res; 2017 Jul; 9(7):638-649. PubMed ID: 28611866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors of treatment response and drop out in the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) study.
    Gabriel D; Jakubovski E; Taylor JH; Artukoglu BB; Bloch MH
    Psychiatry Res; 2017 Sep; 255():248-255. PubMed ID: 28595147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse Events With Sustained-Release Donepezil in Alzheimer Disease: Relation to Body Mass Index.
    Lee C; Lee K; Yu H; Ryu SH; Moon SW; Han C; Lee JY; Lee YM; Kim SG; Kim KW; Lee DW; Kim SY; Lee SY; Bae JN; Jung YE; Kim JL; Kim BS; Shin IS; Kim YH; Kim BJ; Kang HS; Myung W; Carroll BJ; Kim DK
    J Clin Psychopharmacol; 2017 Aug; 37(4):401-404. PubMed ID: 28590369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management.
    Feng XQ; Zhu LL; Zhou Q
    J Pain Res; 2017; 10():1225-1239. PubMed ID: 28579821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.
    Guina J; Roy S; Gupta A; Langleben DD; Elman I
    Hum Psychopharmacol; 2017 Jul; 32(4):. PubMed ID: 28573760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Juncal-Ruiz M; Ramirez-Bonilla M; Gomez-Arnau J; Ortiz-Garcia de la Foz V; Suarez-Pinilla P; Martinez-Garcia O; Neergaard KD; Tabares-Seisdedos R; Crespo-Facorro B
    Psychopharmacology (Berl); 2017 Sep; 234(17):2563-2570. PubMed ID: 28567698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.